Yann Mazabraud - Apr 14, 2025 Form 4 Insider Report for RHYTHM PHARMACEUTICALS, INC. (RYTM)

Role
EVP, Head of International
Signature
/s/ Stephen Vander Stoep, attorney-in-fact for Yann Mazabraud
Stock symbol
RYTM
Transactions as of
Apr 14, 2025
Transactions value $
$0
Form type
4
Date filed
4/16/2025, 04:30 PM
Previous filing
Apr 10, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RYTM Common Stock Options Exercise +10.4K +45.87% 33K Apr 14, 2025 Direct F1
transaction RYTM Common Stock Options Exercise +11.4K +34.57% 44.4K Apr 15, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RYTM Restricted Stock Units Options Exercise $0 -10.4K -33.33% $0.00 20.8K Apr 14, 2025 Common Stock 10.4K Direct F1, F2
transaction RYTM Restricted Stock Units Options Exercise $0 -8.91K -100% $0.00 0 Apr 15, 2025 Common Stock 8.91K Direct F1, F3
transaction RYTM Restricted Stock Units Options Exercise $0 -2.5K -25% $0.00 7.5K Apr 15, 2025 Common Stock 2.5K Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
F2 The restricted stock units vest or have vested as to 25% of the total shares on each of April 14, 2024, April 14, 2025, April 14, 2026 and April 14, 2027. The restricted stock units have no expiration date.
F3 The restricted stock units have vested in full on April 15, 2025. The restricted stock units have no expiration date.
F4 The restricted stock units vest or have vested as to 25% of the total shares on each of April 15, 2025, April 15, 2026, April 15, 2027 and April 15, 2028. The restricted stock units have no expiration date.